Leica Biosystems and Commissioning Agents Sign Agreement to Offer Digital Pathology GLP Validation Services Globally

News provided by

Oct 02, 2014, 01:23 ET

VISTA, California, October 2, 2014 /PRNewswire/ --

Leica Biosystems, the global leader in pathology workflow solutions, announced, today, an agreement with Commissioning Agents, Inc. (CAI) to offer CAI's Good Laboratory Practices Installation Qualification, Operational Qualification, Performance Qualification (GLP IQOQPQ) validation services, globally. The agreement includes GLP IQOQPQ validation services performed by CAI specifically for Leica Biosystems Aperio ePathology slide scanners and associated software.

CAI provides high quality IQOQPQ validation services for Aperio ePathology slide scanners and associated software. (PRNewsFoto/Leica Biosystems)

(Photo: http://photos.prnewswire.com/prnh/20141002/708628 )

"There is a growing demand for our customers to validate their digital pathology products in a GLP environment, especially for the pre-clinical drug development market," said Anne Brumme, vice president of Aperio ePathology at Leica Biosystems. "CAI, experts in hardware and software validation, will enable Leica Biosystems to service its global customers better than ever in a GLP environment. This is particularly important as our Aperio ePathology Solutions are increasingly being installed in global pharmaceutical and contract research organizations (CRO), which are looking to streamline its study workflows."

"We are delighted to be working with Leica Biosystems to fulfill GLP IQOQPQ validation services for its digital pathology customers. Like CAI, Leica Biosystems is a market leader, providing high-quality products to a large and growing customer base," said Tulsa Scott, vice president at CAI. "Commissioning Agents is well positioned to provide validation support as we are executing these services currently for biopharma clients worldwide. Through this agreement with Leica Biosystems, we can expand our business within the pre-clinical segment of the industry."

About Leica Biosystems

Leica Biosystems is a global leader in workflow solutions and automation, striving to advance cancer diagnostics to improve patients' lives. Leica Biosystems provides anatomic pathology laboratories and researchers a comprehensive product range for each step in the pathology process, from sample preparation and staining to imaging and reporting. Leica Biosystems easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence. The company is represented in over 100 countries. The company is headquartered in Nussloch, Germany. Further information can be found at http://www.leicabiosystems.com/

About Commissioning Agents

Commissioning Agents, Inc. is an employee-owned company that provides technical and consulting services globally. They promote the delivery, reliability and efficiency of equipment, facilities, and production operations. Further information can be found at http://www.commissioningagents.com.

SOURCE Leica Biosystems